Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mycobacterium tuberculosis complex differentiation using gyrB-restriction fragment length polymorphism analysis.

Erica Chimara1, Lucilaine Ferrazoli, Sylvia Cardoso Leão

  • 1Setor de Micobactérias, Seção de Bacteriologia, Instituto Adolfo Lutz, Av. Dr. Arnaldo 355, 01246-902 São Paulo, SP, Brazil. echimara@ial.sp.gov.br

Memorias Do Instituto Oswaldo Cruz
|January 18, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Description of new species of <i>Mycobacterium terrae</i> complex isolated from sewage at the São Paulo zoological park foundation in Brazil.

Frontiers in microbiology·2026
Same author

Zoonotic tuberculosis: When diagnostic and surveillance systems are not designed to detect it.

One health (Amsterdam, Netherlands)·2026
Same author

Implementation of the Rapid Molecular Test for Tuberculosis in the State of São Paulo: a Documentary Analysis.

Revista gaucha de enfermagem·2025
Same author

Fifteen years of tuberculosis and HIV diagnostic services in Brazil: disruption, regional disparities, and recovery before, during, and after the COVID-19 pandemic.

IJID regions·2025
Same author

Impact of drug-resistance diagnosis based on whole-genome sequencing on the treatment adequacy of patients with drug-resistant pulmonary tuberculosis in the state of São Paulo, Brazil: a protocol for a non-randomised controlled trial (Gen-TB PróCura).

BMJ open·2025
Same author

Fluoroquinolone and Second-Line Injectable Resistance Among Rifampicin- and Isoniazid-Resistant <i>Mycobacterium tuberculosis</i> Clinical Isolates: A Molecular Study from a High-Burden Setting.

Microorganisms·2025

The gyrB-restriction fragment length polymorphism (gyrB-RFLP) method accurately identifies Mycobacterium tuberculosis complex (MTBC) species. While efficient for differentiating M. tuberculosis and M. bovis, it cannot distinguish between M. bovis and M. bovis BCG.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Genetics

Background:

  • The Mycobacterium tuberculosis complex (MTBC) causes tuberculosis in humans and animals.
  • Accurate differentiation of MTBC species is crucial for effective patient treatment and epidemiological tracking.
  • Traditional methods for MTBC identification can be time-consuming.

Purpose of the Study:

  • To evaluate the gyrB-restriction fragment length polymorphism (gyrB-RFLP) method for differentiating MTBC species.
  • To assess the applicability of gyrB-RFLP in a clinical reference laboratory setting.

Main Methods:

  • Analysis of gyrB-RFLP patterns for six MTBC species.
  • Elaboration of a table based on restriction patterns and published gyrB sequences.
  • Testing gyrB-RFLP on 311 clinical MTBC isolates previously identified by traditional methods.

Related Experiment Videos

Main Results:

  • The gyrB-RFLP method correctly identified all 311 MTBC clinical isolates.
  • No distinction was achieved between M. bovis and M. bovis BCG using gyrB-RFLP.
  • Limitations were observed in differentiating certain subtypes, including M. tuberculosis from M. africanum subtype II, "M. canetti" from M. africanum subtype I, and M. pinnipedii.

Conclusions:

  • GyrB-RFLP is an accurate and user-friendly molecular method for differentiating MTBC species, potentially reducing diagnostic time.
  • The method is valuable for distinguishing M. tuberculosis from M. bovis, which have different treatment regimens.
  • Further refinement is needed for epidemiological studies due to limitations in differentiating closely related MTBC strains.